Use of JC virus antibody index to stratify risk of progressive multifocal leukoencephalopathy in natalizumab-treated patients with multiple sclerosis

被引：0
|
作者：
Plavina, T. [1 ]
Subramanyam, M. [1 ]
Bloomgren, G. [1 ]
Richman, S. [1 ]
Pace, A. [1 ]
Lee, S. [1 ]
Schlain, B. [1 ]
Campagnolo, D. [1 ]
Ticho, B. [1 ]
机构：
[1] Biogen Idec Inc, Weston, MA USA
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O228
引用
收藏
页码：S13 / S13
页数：1
相关论文
共 50 条
  • [41] Cellular response to JC virus: a longitudinal study in a population of natalizumab-treated multiple sclerosis patients
    Masera, S.
    Costa, C.
    Dematteis, F.
    Superti, G.
    Romagnolo, A.
    Mattioda, A.
    Pinessi, L.
    Lopiano, L.
    Cavallo, R.
    Cavalla, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 232 - 233
  • [42] Natalizumab in multiple sclerosis: discontinuation, progressive multifocal leukoencephalopathy and possible use in children
    Vitaliti, Giovanna
    Matin, Nassim
    Tabatabaie, Omidreza
    Di Traglia, Mario
    Pavone, Piero
    Lubrano, Riccardo
    Falsaperla, Raffaele
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (11) : 1321 - 1341
  • [43] Multiple Sclerosis: Risk of progressive multifocal leukoencephalopathy predictable after treatment with natalizumab
    Kriegeskorte, Volker
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2018, 86 (04) : 202 - 202
  • [44] JC virus in multiple sclerosis patients treated with natalizumab
    Inmaculacla Dominguez-Mozo, Maria
    Alvarez-Lafuente, Roberto
    Garcia-Montojo, Marta
    De las Heras, Virginia
    Manuel Bartolome, Francisco
    Arroyo, Rafael
    MULTIPLE SCLEROSIS, 2008, 14 : S39 - S39
  • [45] Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis
    Faulkner, Michele
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (11) : 1737 - 1748
  • [46] JC virus in multiple sclerosis patients treated with natalizumab
    Dominguez-Mozo, M. I.
    Alvarez-Lafuente, R.
    Garcia-Montojo, M.
    De Las Heras, V.
    Bartolome, M.
    Garcia-Martinez, A.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S86 - S86
  • [47] Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
    Heesen, Christoph
    Kleiter, Ingo
    Nguyen, Franziska
    Schaeffler, Nina
    Kasper, Juergen
    Koepke, Sascha
    Gaissmaier, Wolfgang
    MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (12) : 1507 - 1512
  • [48] Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Annette Langer-Gould
    Lawrence Steinman
    Current Neurology and Neuroscience Reports, 2006, 6 : 253 - 258
  • [49] Progressive multifocal leukoencephalopathy and multiple sclerosis: Lessons from natalizumab
    Langer-Gould, Annette
    Steinman, Lawrence
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (03) : 253 - 258
  • [50] Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis
    di Ioia, M.
    Farina, D.
    De Luca, G.
    Travaglini, D.
    Di Tommaso, V.
    Pietrolongo, E.
    Lugaresi, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S132 - S133
12345